243 related articles for article (PubMed ID: 18297705)
21. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
22. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
23. Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients.
Truong BX; Yano Y; Seo Y; Phuong TM; Tanaka Y; Kato H; Miki A; Utsumi T; Azuma T; Trach NK; Mizokami M; Hayashi Y; Kasuga M
J Med Virol; 2007 Sep; 79(9):1293-304. PubMed ID: 17607788
[TBL] [Abstract][Full Text] [Related]
24. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
[TBL] [Abstract][Full Text] [Related]
25. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
[TBL] [Abstract][Full Text] [Related]
27. [Distribution of hepatitis B virus genotype in 5 cities of Fujian province and the clinical implications of HBV genotype].
Hu YY; Jiang JJ; Ou WH; Lin GX; Su ZJ; Liu JJ; Li QG; Yao LF; Lin CW; Li D; Chen Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):251-5. PubMed ID: 15200942
[TBL] [Abstract][Full Text] [Related]
28. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection.
Du H; Li T; Zhang HY; He ZP; Dong QM; Duan XZ; Zhuang H
Liver Int; 2007 Mar; 27(2):240-6. PubMed ID: 17311620
[TBL] [Abstract][Full Text] [Related]
29. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
30. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
31. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
[TBL] [Abstract][Full Text] [Related]
32. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
Wu JC; Huang YH; Chau GY; Su CW; Lai CR; Lee PC; Huo TI; Sheen IJ; Lee SD; Lui WY
J Hepatol; 2009 Nov; 51(5):890-7. PubMed ID: 19747749
[TBL] [Abstract][Full Text] [Related]
34. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.
Tang B; Kruger WD; Chen G; Shen F; Lin WY; Mboup S; London WT; Evans AA
J Med Virol; 2004 Jan; 72(1):35-40. PubMed ID: 14635008
[TBL] [Abstract][Full Text] [Related]
36. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study.
Tangkijvanich P; Theamboonlers A; Sriponthong M; Kullavanijaya P; Poovorawan Y
Am J Gastroenterol; 2003 Nov; 98(11):2500-4. PubMed ID: 14638355
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous quantitation and genotyping of hepatitis B virus by real-time PCR and melting curve analysis.
Payungporn S; Tangkijvanich P; Jantaradsamee P; Theamboonlers A; Poovorawan Y
J Virol Methods; 2004 Sep; 120(2):131-40. PubMed ID: 15288955
[TBL] [Abstract][Full Text] [Related]
39. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.
Li MR; Chen GH; Cai CJ; Wang GY; Zhao H
Digestion; 2011; 84(2):134-41. PubMed ID: 21502763
[TBL] [Abstract][Full Text] [Related]
40. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot study.
Ikeda K; Kobayashi M; Saitoh S; Someya T; Hosaka T; Akuta N; Suzuki Y; Suzuki F; Tsubota A; Arase Y; Kumada H
J Gastroenterol Hepatol; 2005 Jan; 20(1):95-102. PubMed ID: 15610453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]